Blog Articles Will Resume in August
I am on a “writing sabbatical” this summer with limited access to the internet. I will resume posting articles in August. I hope everyone is enjoying their summer!
Similar Posts
How to Figure Out the Cost of Your Medical Care
ByadminHere is a link to an article from CBS News with some very practical advice on this thorny topic. I’m excited to say that some of our research on physician/patient communication was mentioned in the article. Enjoy it! If you’re like most people, you’re paying more for your health care — and stressing about…
Out of Control Physicians: Too Many Doctors Doing Too Many Things to Too Many Patients
ByadminMy father is 92 years old, and I am beginning to wonder whether the best thing for his health would be to stay away from doctors. That’s because well intentioned physicians often expose their elderly patients to harmful and unnecessary services out of habit. That’s certainly the message I absorbed after reading a recent issue…
How Companies Can Save Millions on Healthcare Benefits (without Harming Employees)
ByadminThe free market is supposed to be efficient. Yet employers are throwing away hundreds of millions of dollars, by not giving their employees intelligently designed healthcare benefits that encourage them to shop for affordable lab tests. Right now, when your doctor orders a CBC (complete blood count) and a basic chemistry panel (checking your sodium,…
The Greediest Companies In American Healthcare Are Not Who You Think
ByadminThere’s plenty of price gouging in American healthcare. The pharmaceutical industry has gotten plenty of (well deserved) bad press for its pricing practices. At the extreme are people like “Pharma Bro” (and convicted felon) Martin Shkreli, who hiked the price of an important medication to treat infections in AIDS patients by over 5000%. But high and…
Millions To Be Made On…Generic Drugs?
ByadminIt is well accepted among health economics wonks that the lion’s share of pharmaceutical company profits come when these companies hold exclusive rights to their products. Once their blockbuster pills go “generic,” competitors enter the marketplace and profits plummet. Consider captopril, a groundbreaking heart failure medication introduced in the early 80s by Bristol-Myers Squibb under…